{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:14:11Z","timestamp":1778559251421,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0189"],"award-info":[{"award-number":["P1-0189"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejps.2024.106880","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:10:00Z","timestamp":1724375400000},"page":"106880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The comparison of melt technologies based on mesoporous carriers for improved carvedilol dissolution"],"prefix":"10.1016","volume":"202","author":[{"given":"Mila","family":"Kova\u010devi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrit","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odon","family":"Planin\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O\u017ebej","family":"Zupan\u010di\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Alva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilija","family":"German Ili\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-0168","authenticated-orcid":false,"given":"Alenka","family":"Zvonar Pobirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejps.2024.106880_bib0001","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1208\/s12249-020-01781-2","article-title":"An investigation into the influence of process parameters and formulation variables on compaction properties of liquisolid systems","volume":"21","author":"Aleksi\u0107","year":"2020","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.ejps.2024.106880_bib51","first-page":"1379","article-title":"Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits","volume":"9","author":"Aljimaee","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2024.106880_bib0002","first-page":"4797","article-title":"Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge","volume":"10","author":"Arzani","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2024.106880_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106015","article-title":"Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery","volume":"167","author":"Baumgartner","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2024.106880_bib0004","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s11095-015-1661-y","article-title":"Solvent-free melting techniques for the preparation of lipid-based solid oral formulations","volume":"32","author":"Becker","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106880_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122576","article-title":"Investigating the physicochemical properties of solid dispersions based on semicrystalline carriers: a case study with ketoprofen","volume":"632","author":"Bertoni","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2024.106880_bib0006","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-126913","article-title":"The effect of surfactant type and concentration on physicochemical properties of carvedilol solid dispersions prepared by wet milling method","volume":"21","author":"Bolourchian","year":"2022","journal-title":"Iran. J. Pharm. Res."},{"issue":"6","key":"10.1016\/j.ejps.2024.106880_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJPR\/2017\/33553","article-title":"Mesoporous silica as a carrier for amorphous solid dispersion","volume":"16","author":"Chaudhari","year":"2017","journal-title":"Br. J. Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106880_bib0009","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S84070","article-title":"Soluplus\u24c7\/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan","author":"Cho","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2024.106880_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120377","article-title":"Effects of different physicochemical characteristics and supersaturation principle of solidified SNEDDS and surface-modified microspheres on the bioavailability of carvedilol","volume":"597","author":"Choi","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2024.106880_bib0011","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijpharm.2014.07.043","article-title":"Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods","volume":"473","author":"Chen","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejps.2024.106880_bib0012","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2478\/acph-2013-0040","article-title":"Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs","volume":"63","author":"\u010cerpnjak","year":"2013","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejps.2024.106880_bib0013","unstructured":"European Pharmacopoeia, 11th ed 2023. Council of Europe, Strasbourg, France. Volume 1, pp. 345\u2013347, 359-360, 368-369, 407-413."},{"key":"10.1016\/j.ejps.2024.106880_bib0014","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50 years of oral lipid-based formulations: provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2024.106880_bib0015","unstructured":"Fujichemical Industries, 2015. Neusilin\u24c7 Brochure: 1\u201320. https:\/\/www.fujichemical.co.jp\/english\/medical\/medicine\/neusilin\/neusilin_brochure.pdf (accessed July 5th 2024)."},{"issue":"1","key":"10.1016\/j.ejps.2024.106880_bib0016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.xphs.2017.05.039","article-title":"Hot melt extrusion as solvent-free technique for a continuous manufacturing of drug-loaded mesoporous silica","volume":"107","author":"Genina","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106880_bib0017","unstructured":"Grace & Co-Conn W.R., 2015. Syloid\u24c7 244FP product information: 1\u20132."},{"issue":"9","key":"10.1016\/j.ejps.2024.106880_bib0018","doi-asserted-by":"crossref","first-page":"e05026","DOI":"10.1016\/j.heliyon.2020.e05026","article-title":"Impact of drying on dissolution behavior of carvedilol-loaded sustained release solid dispersion: development and characterization","volume":"6","author":"Halder","year":"2020","journal-title":"Heliyon."},{"issue":"4","key":"10.1016\/j.ejps.2024.106880_bib0019","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/pharmaceutics12040384","article-title":"Importance of mesoporous silica particle size in the stabilization of amorphous pharmaceuticals\u2014the case of simvastatin","volume":"12","author":"Knapik-Kowalczuk","year":"2020","journal-title":"Pharmaceutics."},{"issue":"4","key":"10.1016\/j.ejps.2024.106880_bib0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/pharmaceutics14040818","article-title":"Comparative study of powder carriers physical and structural properties","volume":"14","author":"Kostelansk\u00e1","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2024.106880_bib0021","article-title":"The effect of polymeric binder type and concentration on flow and dissolution properties of SMEDDS loaded mesoporous silica-based granules","volume":"193","author":"Kova\u010devi\u0107","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejps.2024.106880_bib0022","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/pharmaceutics14102077","article-title":"High-shear wet granulation of SMEDDS based on mesoporous carriers for improved carvedilol solubility","volume":"14","author":"Kova\u010devi\u0107","year":"2022","journal-title":"Pharmaceutics."},{"issue":"4","key":"10.1016\/j.ejps.2024.106880_bib0023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1248\/cpb.59.427","article-title":"Solid dispersions of carvedilol with porous silica","volume":"59","author":"Kova\u010di\u010d","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejps.2024.106880_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105343","article-title":"Binary polymeric amorphous carvedilol solid dispersions: in vitro and in vivo characterization","volume":"150","author":"Krsti\u0107","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2024.106880_bib0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1208\/s12249-014-0247-z","article-title":"Preformulation studies on solid self-emulsifying systems in powder form containing magnesium Aluminometasilicate as porous carrier","volume":"16","author":"Krupa","year":"2015","journal-title":"AAPS. PharmSciTech."},{"issue":"1","key":"10.1016\/j.ejps.2024.106880_bib0026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12272-011-0106-3","article-title":"Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50\/13","volume":"34","author":"Kumar Potluri","year":"2011","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2024.106880_bib0027","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2012.04.066","article-title":"Emerging trends in the stabilization of amorphous drugs","volume":"453","author":"Laitinen","year":"2013","journal-title":"Int J Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2024.106880_bib0028","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejps.2011.11.025","article-title":"Soluplus\u24c7 as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo","volume":"45","author":"Linn","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2024.106880_bib0029","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1208\/s12249-011-9750-7","article-title":"Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability","volume":"13","author":"Liu","year":"2012","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.ejps.2024.106880_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120783","article-title":"Evaluation of solid carvedilol-loaded SMEDDS produced by the spray drying method and a study of related substances","volume":"605","author":"Mandi\u0107","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106880_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119377","article-title":"Solidification of SMEDDS by fluid bed granulation and manufacturing of fast drug release tablets","volume":"583","author":"Mandi\u0107","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106880_bib0032","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2019.05.055","article-title":"Solidification of carvedilol loaded SMEDDS by swirling fluidized bed pellet coating","volume":"566","author":"Mandi\u0107","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2024.106880_bib0033","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/17425247.2016.1100165","article-title":"Mesoporous silica formulation strategies for drug dissolution enhancement: a review","volume":"13","author":"McCarthy","year":"2016","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ejps.2024.106880_bib0034","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3109\/10717544.2016.1165314","article-title":"Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation","volume":"23","author":"Mishra","year":"2016","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.ejps.2024.106880_bib0035","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1208\/s12249-014-0134-7","article-title":"A comparison of granules produced by high-shear and fluidized-bed granulation methods","volume":"15","author":"Morin","year":"2014","journal-title":"AAPS. PharmSciTech."},{"issue":"5","key":"10.1016\/j.ejps.2024.106880_bib0036","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003088-199426050-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of carvedilol","volume":"26","author":"Morgan","year":"1994","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.ejps.2024.106880_bib0037","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.cherd.2010.08.006","article-title":"Binder addition methods and binder distribution in high shear and fluidised bed granulation","volume":"89","author":"Osborne","year":"2011","journal-title":"Chem. Eng. Res. Des."},{"key":"10.1016\/j.ejps.2024.106880_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121294","article-title":"Mixed micelles formulation for carvedilol delivery: in-vitro characterization and in-vivo evaluation","volume":"611","author":"\u00d6zt\u00fcrk","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106880_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119560","article-title":"Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products","volume":"586","author":"Pandi","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"14","key":"10.1016\/j.ejps.2024.106880_bib0040","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2217\/pgs-2018-0115","article-title":"Clinical pharmacogenomics of carvedilol: the stereo-selective metabolism angle","volume":"19","author":"Parker","year":"2018","journal-title":"Pharmacogenomics."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2024.106880_bib0041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2010.12.035","article-title":"Carvedilol dissolution improvement by preparation of solid dispersions with porous silica","volume":"406","author":"Planin\u0161ek","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"22","key":"10.1016\/j.ejps.2024.106880_bib0042","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.3390\/polym14224977","article-title":"Carvedilol precipitation inhibition by the incorporation of polymeric precipitation inhibitors using a stable amorphous solid dispersion approach: formulation, characterization, and in vitro in vivo evaluation","volume":"14","author":"Ravikumar","year":"2022","journal-title":"Polymers."},{"key":"10.1016\/j.ejps.2024.106880_bib0043","series-title":"Handbook of pharmaceutical excipients","author":"Rowe","year":"2009"},{"issue":"1","key":"10.1016\/j.ejps.2024.106880_bib0044","first-page":"49","article-title":"Preparation and characterization of solid dispersions of carvedilol with PVP K30","volume":"5","author":"Sharma","year":"2010","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106880_bib0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijbiomac.2019.05.162","article-title":"Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: optimization and pharmacokinetic study","volume":"135","author":"Sharma","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.ejps.2024.106880_bib0046","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/10717544.2011.604686","article-title":"Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential","volume":"18","author":"Singh","year":"2011","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2024.106880_bib0047","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejpb.2021.04.017","article-title":"Insights into the ameliorating ability of mesoporous silica in modulating drug release in ternary amorphous solid dispersion prepared by hot melt extrusion","volume":"165","author":"Solomon","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejps.2024.106880_bib0048","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s10973-013-3491-7","article-title":"Carvedilol: decomposition kinetics and compatibility with pharmaceutical excipients","volume":"115","author":"Talvani","year":"2014","journal-title":"J. Therm. Anal. Calorim."},{"issue":"6","key":"10.1016\/j.ejps.2024.106880_bib0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2174\/1567201819666220721111852","article-title":"Role of fine silica as amorphous solid dispersion carriers for enhancing drug load and preventing recrystallization- a comprehensive review","volume":"20","author":"Trivedi","year":"2023","journal-title":"Curr. Drug Deliv."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:56:54Z","timestamp":1778558214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":49,"alternative-id":["S0928098724001921"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106880","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The comparison of melt technologies based on mesoporous carriers for improved carvedilol dissolution","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106880"}}